There were three questions related to M&A in Pharma - Market opportunity of targets, recommendations on what to buy and what to do about the current portfolio of drugs. I was given a short brief, a slide pack of 15 slides (full disclosure - 5 were title slides, the other 10 were pretty densely populated with data. Not a Word document but not far off in some cases) and 3 questions to answer. It felt less like a test of how you thought and more a test of whether you could find the right piece of information buried in a mass of data under the pressure of time. Although I accept that finding data is an important aspect of consulting it is generally more about asking the right questions to get you there quickly and less about reading over reams of data and picking the right piece.
